All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Human immune deficiency virus (HIV) and malnutrition has multifaceted and multidirectional relationships. Both are related each other in causing progressive damage to the immune system. HIV compromises nutritional status and poor nutrition further weakness the immune system of individuals, increasing susceptibility to opportunistic infections. HIV can cause or worsen malnutrition by triggering reduced food uptake, increased energy requirements and poor nutrient absorptions \[[@pone.0229883.ref001]--[@pone.0229883.ref003]\].

Poor nutritional status is one of the major complications of HIV and a significant factor in a full-blown AIDS. In most resource limited settings, many people who become infected with HIV may already be undernourished due to factors such as unemployment and difficulty to procure food. Food insecurity and malnutrition remained the major challenge in the progresses made to avert morbidity and mortality attributed to HIV/AIDS. Food insecurity contributes to high risk sexual behaviors, inconsistent condom use and multiple partnership. While, malnutrition leads to ART non-adherence among HIV/AIDS patients \[[@pone.0229883.ref004],[@pone.0229883.ref005]\].

In Sub-Saharan Africa region, malnutrition (both undernutrition and overweight) was prevalent among HIV/AIDS patients enrolled in care \[[@pone.0229883.ref006]--[@pone.0229883.ref008]\]. The prevalence of adult undernutrition was 19% in Tanzania \[[@pone.0229883.ref006]\], 10% in Zimbabwe \[[@pone.0229883.ref007]\] and 19% in Senegal \[[@pone.0229883.ref009]\]. The prevalence of malnutrition was also high in Ethiopia; 25.2% in Butajira hospital \[[@pone.0229883.ref010]\] and 12.3% in Dilla university hospital \[[@pone.0229883.ref011]\]. The main determinants of malnutrition ranges from individual level factors to underlying factors. The high prevalence of malnutrition was determined by wealth index and educational attainment, where malnutrition decreased with increase in wealth index and educational attainment \[[@pone.0229883.ref012]\]. A lower CD4 cell count, sex, age, advanced HIV diseases, presence of opportunistic infections, adherence concern, inability to access food and having social support were also significantly associated with malnutrition \[[@pone.0229883.ref006],[@pone.0229883.ref007],[@pone.0229883.ref009],[@pone.0229883.ref013]\]. Malnutrition is less likely in females and older ages (35--44 years and ≥45 years) compared to 15--24 years. Having social support and informal care giving has also reduced the odds of undernutrition \[[@pone.0229883.ref013]\]. On the contrary, malnutrition is more likely in those who had advanced HIV disease \[[@pone.0229883.ref006],[@pone.0229883.ref007],[@pone.0229883.ref009]\].

Despite remarkable efforts are made in increasing the treatment coverage of HIV/AIDS in the past decades, the high prevalence of HIV/AIDS and malnutrition has remained the major challenges of health systems in SSA region \[[@pone.0229883.ref014]\]. This was commonly attributed to the low treatment effectiveness due to factors such as non-adherence, quality and nutritional status of patients \[[@pone.0229883.ref015],[@pone.0229883.ref016]\].

Ethiopia has also significantly improved the treatment coverage in the past decades and as the consequence of this promising results were observed. HIV/AIDS treatment coverage was reached to 71% in 2017. Between 2000 and 2017, new HIV infections were reduced by 90% and AIDS related mortality was reduced among adults by more than 50% \[[@pone.0229883.ref017]\].

However, HIV/AIDS prevalence remained high (0.9%) in Ethiopia \[[@pone.0229883.ref018]\] and in 2017 there were an estimated 613,000 people living with HIV/AIDS (out of which 29% were lacked access to treatments). Ethiopia is one among the 25 countries worldwide and 17 countries in Africa region with the highest number of new HIV infections \[[@pone.0229883.ref017]\]. This calls for attention in improving the treatment effectiveness of existing HIV/AIDS services and one of the focus areas of this actions was strengthening the nutritional assessment, care and support services for HIV/AIDS patients. Hence, this study was aimed to estimate the prevalence of malnutrition (undernutrition and overweight or obesity) among adult HIV/AIDS patients enrolled in HIV/AIDS care in the period between 2010 and 2016 at Jimma Medical Center, a tertiary hospital in Ethiopia with an established HIV/AIDS treatment program. We also identified the predictors of undernutrition among HIV/AIDS patients.

Materials and methods {#sec006}
=====================

Study setting {#sec007}
-------------

Jimma Medical Center, formerly known as Jimma University Specialized Hospital, was one of the teaching hospitals in Ethiopia located in Jimma city administration, 355km Southwest direction of the capital city, Addis Ababa. It is a government hospital which is an affiliate of Jimma University providing trainings for health science students in a range of disciples. The hospital also provides a higher level of clinical care for around 15 million catchment population located in Southwest part of Ethiopia. The hospital has 36 departments, of which ART clinic was one among them. Since 2005, the hospital has been providing highly active antiretroviral therapy (HAART) for people living with HIV/AIDS (PLWHA). During the study period (July 2010 to January 2016), a total of 5554 patients were on HAART.

Study design {#sec008}
------------

Facility based cross-sectional study design was conducted. Data were collected retrospectively from clinical records of HIV/AIDS patients enrolled for follow-up care in ART clinic from July 2010 to January 2016. We retrieved data from patient cards and ART log books of adults (\>15 years) from March to April 2016.

Study participants selection {#sec009}
----------------------------

The study participants were cohort of adult HIV/AIDS patients (age \>15 years old) on follow-up care. The sample size was computed using OpenEpi Version 3 sample size calculator for proportions by using assumptions of a 95% CI, the outcome factor in the population of 46.8% \[[@pone.0229883.ref019]\], margin of error 3% and design effect of(DEFF) of 1. The calculated sample size yields 1062.

Sample size formula (n) = \[DEFF\*Np (1-p)\]/ \[(d^2^/Z^2^~1-α/2~\*(N-1) +p\*(1-p)\]; where DEFF was design effect and N~p~ was the prevalence of outcome variable in the population (i.e., the prevalence of malnutrition).

The study participants were selected by using a systematic sampling strategy; where the clinical records of ART clients from July 2010 to January 2016 were used as a sampling frame. First, a sequential number starting from 1001 were provided to each records. The first record of a patient was selected using lottery method and every K^th^ records (K = 5) were included. The value of K was obtained by dividing the total ART patients (5554) for the sample size (n = 1062).

HIV/AIDS patients who have a follow-up care in the same facility and that have key baseline information's such as demographic characteristics (age, ethnicity, and marital status) and clinical information (such as CD4 count, viral load, WHO clinical stage, weight, height, and hemoglobin level) were eligible for this study. In case when records have missed information on one of the variables, it was excluded.

Measurement {#sec010}
-----------

A data collection tool, having the same structure with ART register and patient cards, was used to collect data. The tool comprised of components such as patient background information's, immunologic status, clinical and laboratory examinations (CD4 count, viral load, WHO clinical stage, weight, height) and antiretroviral regimen and opportunistic infection prophylaxis. Three clinicians who had also trained on ART service provision were recruited for data collection. Furthermore, one supervisor with background of health was recruited and monitored the overall process of data collection.

Data were collected from ART unit of the hospital in the following processes. First, data collectors approached the unit and obtained permission. Following this, patient records between July 2010 to January 2016 were retrieved from catalogs and the first patient record was selected randomly. In case when the selected patient record had incomplete information, it was dropped and the next patient record was included and reviewed. The data collection process was continued in such a way until the final sample size was attained.

Statistical analysis {#sec011}
--------------------

Data were checked for consistency and completeness. Then it was entered into epidata version 3.1 and exported to SPSS version 21. Descriptive statistics were conducted and variables were presented using mean, frequencies and proportion. Body Mass Index (BMI) was calculated as weight in kilograms divided by the squares of height in meters (kg/m^2^). For the initial analysis, BMI was stratified into the WHO criteria: \<18.5 (undernutrition), \>18.5 to 25 (normal nutrition) and \>25 kg/m^2^ (overweight or obese). In this study both undernutrition (BMI \<18.5 kg/m^2^) and overweight or obesity (BMI\>25 kg/m^2^) were estimated \[[@pone.0229883.ref003]\]. Independent predictors of adult undernutrition in adult HIV/AIDS patients (such as socio-demographic and clinical characteristics) were determined by using bivariate and multivariate logistic regression analysis. In the bivariate analysis those variables with P-value \< 0.05 were considered candidate variables to multivariate logistic regression model. In the multivariate analysis variables with P-value of \< 0.05 were considered statistically significant and interpreted.

The covariates of the multivariate analysis were selected using enter method. While, the model fitness (goodness) was assessed by using Wald test for individual variables and maximum likelihood ratio test for the overall model.

Ethical consideration {#sec012}
---------------------

Research protocol was submitted to the Institute of Health of Jimma university and ethical approval was obtained (Ref no. RPGC/26/2016; March, 2016). Primarily research permission was obtained from authorities of Jimma Medical Center to access patient records for review and informed consent was not obtained from patients due to the difficulty of accessing every patients. We have accessed anonymized patient information that comprised only unique ART number of the patient and other relevant data for research. The confidentiality of all patient information was maintained through use of codes, where we have provided a sequential code to each patients starting from 1001. Paper-based data were kept in a locked cabinet and computer-based data were secured with passwords. Except the research team members, no one could access patient data. Whenever a need arises, patient data will be shared to a third party by following the legal and ethical guidelines.

Results {#sec013}
=======

Out of the total patient records (n = 1062), 357 were undernutrition patient records, 614 were normal nutrition patient records and 91 were overweight patient records. While undernutrition and normal nutrition patient records were considered in the multivariate analysis (n = 971), we reported only the prevalence of overweight patients (n = 91) ("[Fig 1](#pone.0229883.g001){ref-type="fig"}").

![Study flow diagram.](pone.0229883.g001){#pone.0229883.g001}

Characteristics of patients {#sec014}
---------------------------

[Table 1](#pone.0229883.t001){ref-type="table"} presented the demographic, socio-demographic and clinical characteristics of patients on HIV/AIDS follow-care by nutritional status (undernutrition, normal nutrition and overweight or obesity).

10.1371/journal.pone.0229883.t001

###### Socio-demographic and clinical characteristics of patients grouped by nutritional status (BMI[^a^](#t001fn001){ref-type="table-fn"}) in Jimma Medical Center, Southwest Ethiopia, 2016.

![](pone.0229883.t001){#pone.0229883.t001g}

  ----------------------------------------------------------------------------------------------------------------------------------------
  Variable                                                         Undernutrition\   Normal nutrition\   Overweight or obese\   Total\
                                                                   No (%)            No (%)              No (%)                 No (%)
  ---------------------------------------------------------------- ----------------- ------------------- ---------------------- ----------
  Gender                                                                                                                        

   Male                                                            149(42)           241(39)             23(25)                 413(39)

   Female                                                          208(58)           373(61)             68(75)                 649(61)

  Age group (years)                                                                                                             

   16-\<30                                                         149(42)           253(41)             30(33)                 432(41)

   30--39                                                          141(39)           227(37)             33(36)                 401(38)

   40--49                                                          51(14)            100(16)             19(21)                 170(16)

   \>=50                                                           16(4)             34(6)               9(10)                  59(6)

  Marital status                                                                                                                

   Married                                                         156(44)           308(50)             51(56)                 515(48)

   Never married/ single                                           66(18)            98(16)              13(14)                 177(17)

   Separated                                                       52(15)            93(15)              5(5)                   150(14)

   Divorced                                                        30(8)             52(8)               11(12)                 93(9)

   Widowed                                                         53(15)            63(10)              11(12)                 127(12)

  Religious status                                                                                                              

   Muslim                                                          120(34)           188(31)             34(37)                 342(32)

   Orthodox                                                        196(55)           369(60)             47(52)                 612(58)

   Protestant                                                      39(11)            53(9)               8(9)                   100(9)

   Catholic                                                        2(1)              4(1)                2(2)                   8(1)

  Educational status                                                                                                            

   No education                                                    62(17)            126(21)             12(13)                 200(19)

   Primary education                                               160(45)           267(43)             35(38)                 462(44)

   Secondary education                                             102(29)           164(27)             20(22)                 286(27)

   Tertiary education                                              33(9)             57(9)               24(26)                 114(11)

  Employment status                                                                                                             

   Employed                                                        134(38)           293(48)             46(51)                 473(45)

   Unemployed                                                      223(62)           321(52)             45(49)                 589(55)

  Accessed to water supply                                                                                                      

   Yes                                                             285(80)           525(86)             76(84)                 886(83)

   No                                                              72(20)            89(14)              15(16)                 176(17)

  Accessed to electricity                                                                                                       

   Yes                                                             346(97)           598(97)             90(99)                 1034(97)

   No                                                              11(3)             16(3)               1(1)                   28(3)

  WHO[^b^](#t001fn002){ref-type="table-fn"} clinical staging                                                                    

   Stage one                                                       58(16)            180(29)             44(48)                 282(27)

   Stage two                                                       73(20)            215(35)             25(27)                 313(29)

   Stage three                                                     154(43)           172(28)             14(15)                 340(32)

   Stage four                                                      72(20)            47(8)               8(9)                   127(12)

  CD4 cell count                                                                                                                

   \<200                                                           239(67)           303(49)             26(29)                 568(53)

   ≥200                                                            118(33)           311(51)             65(71)                 494(47)

  Functional status                                                                                                             

   Ambulatory                                                      112(31)           73(12)              4(4)                   189(18)

   Bed ridden                                                      22(6)             9(1)                1(1)                   32(3)

   Working                                                         223(62)           532(87)             86(95)                 841(79)

  Patient past opportunistic infection                                                                                          

   Yes                                                             297(83)           508(83)             68(75)                 873(82)

   No                                                              60(17)            106(17)             23(25)                 189(18)

  HIV/AIDS disclosure status                                                                                                    

   Yes                                                             296(83)           549(89)             86(95)                 931(88)

   No                                                              61(17)            65(11)              5(5)                   131(12)

  Accessed to spiritual care giver                                                                                              

   Yes                                                             191(54)           324(53)             43(47)                 558(53)

   No                                                              166(46)           290(47)             48(53)                 504(47)

  Accessed to community HIV support group                                                                                       

   Yes                                                             106(30)           184(30)             26(29)                 316(30)

   No                                                              251(70)           430(70)             65(71)                 746(70)

  Attended HIV related counseling session                                                                                       

   Yes                                                             153(43)           259(42)             51(56)                 463(44)

   No                                                              204(57)           355(58)             40(44)                 599(56)

  Attended HIV related health education session                                                                                 

   Yes                                                             258(72)           486(79)             72(79)                 816(77)

   No                                                              99(28)            128(21)             19(21)                 246(23)

  Diagnosed for active TB[^c^](#t001fn003){ref-type="table-fn"}                                                                 

   Yes                                                             63(18)            65(11)              4(4)                   132(12)

   No                                                              294(82)           549(89)             87(96)                 930(88)

  Adherence concern to ART[^d^](#t001fn004){ref-type="table-fn"}                                                                

   Stigma                                                          252(71)           435(71)             64(70)                 751(71)

   Afraid of medications (side effects)                            44(12)            67(11)              9(10)                  120(11)

   Doubt that medications will work                                22(6)             38(6)               5(5)                   65(6)

   Depressed or anxious                                            27(8)             54(9)               9(10)                  90(8)

   Will forget to take medications                                 12(3)             20(3)               4(4)                   36(3)
  ----------------------------------------------------------------------------------------------------------------------------------------

^a^Body Mass Index;

^b^World Health Organization;

^c^Tuberculosis;

^d^Antiretroviral Therapy

Majority of the patients were female (61%) and in the age group of \<30 years (41%). Nearly half (48%) of them were married and a bit over half of them were followers of orthodox religion (58%). While slightly over four in ten (44%) of patients have attended primary education, most (89%) were unemployed ("[Table 1](#pone.0229883.t001){ref-type="table"}").

With regards to the clinical characteristics, most of patients have disclosed their HIV status to either a friend or family member (88%) and a bit over three-fourth of them have attended HIV related health education sessions previously (77%). Nearly one-thirds of patients were in the WHO clinical stage two (29%) and another 32% of patients were in the WHO clinical stage three at the start of HIV treatment (ART). Moreover, slightly over half (53%) had CD4 cell count \<200 and over three-fourth (79%) of the patients had a working functional status.

The mean and median BMI of patients were 19.99 kg/m^2^ (SD 3.41) and 19.56 kg/m^2^, respectively. The proportion of undernutrition (BMI\<18.5 kg/m^2^), normal nutrition (BMI 18.5--24.9 kg/m^2^) and overweight or obese (BMI≥25 kg/m^2^) patients were 34%, 58% and 9%, respectively. Out of undernutrition patients, severe malnutrition (BMI\<16 kg/m^2^) accounted of 9% ("[Fig 2](#pone.0229883.g002){ref-type="fig"}").

![Nutritional status of HIV/AIDS patients on follow-up care at Jimma Medical Center, Southwest Ethiopia, 2016.](pone.0229883.g002){#pone.0229883.g002}

Undernutrition was higher in female patients (58%) and patients in the age group of \<30 years old (42%). Likewise, the proportion of undernutrition was higher in married (44%), orthodox religion follower (55%), primary education level (45%) and unemployed (62%) patients ("[Table 1](#pone.0229883.t001){ref-type="table"}").

Looking a closer at the distribution of undernutrition with patients' clinical characteristics, undernutrition was higher in patients with WHO clinical stage three (43%), patients with a CD4 cell count \<200 cells/mm^3^ (67%) and patients with past opportunistic infections (OI's) (62%). Whereas, patients who have disclosed their HIV status (83%) and those patients with a working functional status (62%) had a higher proportions of undernutrition.

Overweight or obesity was higher among female patients (75%) and patients in the age group of 30--39 years old (36%). Overweight or obesity was also higher in married (56%), orthodox religion follower (52%) and primary educational level (38%) patients. While nearly half of overweight or obese patients were in the WHO clinical stage one (48%), majority had a CD4 cell count ≥200 cells/mm^3^ (71%) and working functional status (95%).

Predictors of undernutrition {#sec015}
----------------------------

[Table 2](#pone.0229883.t002){ref-type="table"} presented the bivariate analysis results of undernutrition and the different independent variables. In the bivariate logistic regression analysis, marital status, employment status, access to water supply, HIV disclosure status, WHO clinical staging, CD4 cell count, functional status, attending HIV related health education sessions and being diagnosed for active TB were associated with undernutrition. These independent variables were candidates for multivariate logistic regression analysis ("[Table 2](#pone.0229883.t002){ref-type="table"}").

10.1371/journal.pone.0229883.t002

###### Bivariate association of different variables with undernutrition among HIV/AIDS patients on follow-up care in Jimma Medical Center, Southwest Ethiopia, 2016.

![](pone.0229883.t002){#pone.0229883.t002g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                                          Undernutrition\   Normal nutrition\   COR[^a^](#t002fn001){ref-type="table-fn"} (95% CI[^b^](#t002fn002){ref-type="table-fn"})
                                                                    n (%)             n (%)               
  ----------------------------------------------------------------- ----------------- ------------------- ------------------------------------------------------------------------------------------
  Sex                                                                                                     

   Male                                                             149(42)           241(39)             Ref

   Female                                                           208(58)           373(61)             0.90(0.69--1.18)

  Age group (years)                                                                                       

   16-\<30                                                          149(42)           253(41)             Ref

   30--39                                                           141(39)           227(37)             1.06(0.79--1.41)

   40--49                                                           51(14)            100(16)             0.87(0.58--1.28)

   \>=50                                                            16(4)             34(6)               0.79(0.43--1.49)

  Marital status                                                                                          

   Married                                                          156(44)           308(50)             Ref

   Never married/ single                                            66(18)            98(16)              1.33(0.92--1.92)

   Separated                                                        52(15)            93(15)              1.10(0.75--1.63)

   Divorced                                                         30(8)             52(8)               1.14(0.69--1.86)

   Widowed                                                          53(15)            63(10)              1.66(1.09--2.51)[\*](#t002fn006){ref-type="table-fn"}

  Religious status                                                                                        

   Muslim                                                           120(34)           188(31)             Ref

   Orthodox                                                         196(55)           369(60)             0.83(0.62--1.11)

   Protestant                                                       39(11)            53(9)               1.15(0.72--1.85)

   Catholic                                                         2(1)              4(1)                0.78(0.14--4.34)

  Educational status                                                                                      

   No education                                                     62(17)            126(21)             Ref

   Primary education                                                160(45)           267(43)             1.22(0.85--1.75)

   Secondary education                                              102(29)           164(27)             1.26(0.85--1.87)

   Tertiary education                                               33(9)             57(9)               1.18(0.69--1.99)

  Employment status                                                                                       

   Employed                                                         134(38)           293(48)             Ref

   Unemployed                                                       223(62)           321(52)             1.52(1.16--1.98)[\*](#t002fn006){ref-type="table-fn"}

  Accessed to water supply                                                                                

   Yes                                                              285(80)           525(86)             Ref

   No                                                               72(20)            89(14)              1.49(1.06--2.09)[\*](#t002fn006){ref-type="table-fn"}

  Accessed to electricity                                                                                 

   Yes                                                              346(97)           598(97)             Ref

   No                                                               11(3)             16(3)               1.19(0.55--2.59)

  WHO[^c^](#t002fn003){ref-type="table-fn"} clinical staging                                              

   Stage one                                                        58(16)            180(29)             Ref

   Stage two                                                        73(20)            215(35)             1.05(0.71--1.57)

   Stage three                                                      154(43)           172(28)             2.78(1.93--4.01)[\*](#t002fn006){ref-type="table-fn"}

   Stage four                                                       72(20)            47(8)               4.75(2.97--7.62)[\*](#t002fn006){ref-type="table-fn"}

  CD4 cell count (cells/mm^3^)                                                                            

   \<200                                                            239(67)           303(49)             2.08(1.59--2.73)[\*](#t002fn006){ref-type="table-fn"}

   ≥200                                                             118(33)           311(51)             Ref

  Functional status                                                                                       

   Ambulatory                                                       112(31)           73(12)              3.66(2.62--5.11)[\*](#t002fn006){ref-type="table-fn"}

   Bed ridden                                                       22(6)             9(1)                5.83(2.64--12.86)[\*](#t002fn006){ref-type="table-fn"}

   Working                                                          223(62)           532(87)             Ref

  Patients' past opportunistic infections                                                                 

   Yes                                                              297(83)           508(83)             1.03(0.73--1.46)

   No                                                               60(17)            106(17)             Ref

  HIV/AIDS disclosure status                                                                              

   Yes                                                              296(83)           549(89)             0.58(0.39--0.84)[\*](#t002fn006){ref-type="table-fn"}

   No                                                               61(17)            65(11)              Ref

  Accessed to spiritual care giver                                                                        

   Yes                                                              191(54)           324(53)             1.03(0.79--1.34)

   No                                                               166(46)           290(47)             Ref

  Accessed to community HIV support group                                                                 

   Yes                                                              106(30)           184(30)             1.01(0.76--1.35)

   No                                                               251(70)           430(70)             Ref

  Attended HIV related counseling session                                                                 

   Yes                                                              153(43)           259(42)             1.03(0.79--1.34)

   No                                                               204(57)           355(58)             Ref

  Attended HIV related health education session                                                           

   Yes                                                              258(72)           486(79)             0.69(0.51--0.93)[\*](#t002fn006){ref-type="table-fn"}

   No                                                               99(28)            128(21)             Ref

  Diagnosed for active TB[^d^](#t002fn004){ref-type="table-fn"}                                           

   Yes                                                              63(18)            65(11)              1.81(1.25--2.63)[\*](#t002fn006){ref-type="table-fn"}

   No                                                               294(82)           549(89)             Ref

  Adherence concerns to ART[^e^](#t002fn005){ref-type="table-fn"}                                         

   Stigma                                                           252(71)           435(71)             Ref

   Afraid of medications (side effects)                             44(12)            67(11)              1.13(0.75--1.71)

   Doubt that medications will work                                 22(6)             38(6)               0.99(0.58--1.73)

   Depressed or anxious                                             27(8)             54(9)               0.86(0.53--1.41)

   Will forget to take medications                                  12(3)             20(3)               1.04(0.49--2.15)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Crude (unadjusted) odds ratio;

^b^Confidence interval;

^c^World Health Organization;

^d^Tuberculosis;

^e^Antiretroviral Therapy

\*P-value\<0.05

[Table 3](#pone.0229883.t003){ref-type="table"} presented the multivariate logistic regression analysis result. In the multivariate logistic regression analysis, marital status, access to water supply, WHO clinical staging, CD4 cell count and patient functional status were identified as independent predictors of undernutrition ("[Table 3](#pone.0229883.t003){ref-type="table"}").

10.1371/journal.pone.0229883.t003

###### Multivariate association of different variables with undernutrition among HIV/AIDS patients on follow-up care in Jimma Medical Center, Southwest Ethiopia, 2016.

![](pone.0229883.t003){#pone.0229883.t003g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                                        Undernutrition\   Normal nutrition\   COR[^a^](#t003fn001){ref-type="table-fn"} (95% CI[^b^](#t003fn002){ref-type="table-fn"})   AOR[^c^](#t003fn003){ref-type="table-fn"}(95% CI)
                                                                  No (%)            No (%)                                                                                                         
  --------------------------------------------------------------- ----------------- ------------------- ------------------------------------------------------------------------------------------ -------------------------------------------------------
  Marital status                                                                                                                                                                                   

   Married                                                        156(44)           308(50)             Ref                                                                                        Ref

   Never married/ single                                          66(18)            98(16)              1.33(0.92--1.92)                                                                           1.31(0.87--1.96)

   Separated                                                      52(15)            93(15)              1.10(0.75--1.63)                                                                           0.96(0.62--1.48)

   Divorced                                                       30(8)             52(8)               1.14(0.69--1.86)                                                                           1.11 (0.65--1.91)

   Widowed                                                        53(15)            63(10)              1.66 (1.09--2.51)[\*](#t003fn006){ref-type="table-fn"}                                     1.7(1.03--2.79)[\*](#t003fn006){ref-type="table-fn"}

  Employment status                                                                                                                                                                                

   Employed                                                       134(38)           293(48)             Ref                                                                                        Ref

   Unemployed                                                     223(62)           321(52)             1.52(1.16--1.98)[\*](#t003fn006){ref-type="table-fn"}                                      1.29(0.96--1.74)

  Accessed to water supply                                                                                                                                                                         

   Yes                                                            285(80)           525(86)             Ref                                                                                        Ref

   No                                                             72(20)            89(14)              1.49(1.06--2.09)[\*](#t003fn006){ref-type="table-fn"}                                      1.69(1.16--2.47)[\*](#t003fn006){ref-type="table-fn"}

  WHO[^d^](#t003fn004){ref-type="table-fn"} clinical staging                                                                                                                                       

   Stage one                                                      58(16)            180(29)             Ref                                                                                        Ref

   Stage two                                                      73(20)            215(35)             1.05(0.71--1.57)                                                                           0.92(0.61--1.39)

   Stage three                                                    154(43)           172(28)             2.78(1.93--4.01)[\*](#t003fn006){ref-type="table-fn"}                                      1.99(1.33--2.97)[\*](#t003fn006){ref-type="table-fn"}

   Stage four                                                     72(20)            47(8)               4.75(2.97--7.62)[\*](#t003fn006){ref-type="table-fn"}                                      2.97(1.74--5.07)[\*](#t003fn006){ref-type="table-fn"}

  CD4 cell count cells/mm^3^                                                                                                                                                                       

   \<200                                                          239(67)           303(49)             2.08(1.59--2.73)[\*](#t003fn006){ref-type="table-fn"}                                      1.85(1.38--2.47)[\*](#t003fn006){ref-type="table-fn"}

   ≥200                                                           118(33)           311(51)             Ref                                                                                        Ref

  Functional status                                                                                                                                                                                

   Ambulatory                                                     112(31)           73(12)              3.66(2.62--5.11)[\*](#t003fn006){ref-type="table-fn"}                                      2.41(1.66--3.51)[\*](#t003fn006){ref-type="table-fn"}

   Bed ridden                                                     22(6)             9(1)                5.83(2.64--12.86)[\*](#t003fn006){ref-type="table-fn"}                                     3.59(1.55--8.35)[\*](#t003fn006){ref-type="table-fn"}

   Working                                                        223(62)           532(87)             Ref                                                                                        Ref

  HIV disclosure status                                                                                                                                                                            

   Yes                                                            296(83)           549(89)             0.58(0.39--0.84)[\*](#t003fn006){ref-type="table-fn"}                                      0.75(0.49--1.15)

   No                                                             61(17)            65(11)              Ref                                                                                        Ref

  Attended HIV related health education session                                                                                                                                                    

   Yes                                                            258(72)           486(79)             0.69(0.51--0.93)[\*](#t003fn006){ref-type="table-fn"}                                      0.80 (0.57--1.13)

   No                                                             99(28)            128(21)             Ref                                                                                        Ref

  Diagnosed for active TB[^e^](#t003fn005){ref-type="table-fn"}                                                                                                                                    

   Yes                                                            63(18)            65(11)              1.81(1.25--2.63)[\*](#t003fn006){ref-type="table-fn"}                                      0.83(0.53--1.29)

   No                                                             294(82)           549(89)             Ref                                                                                        Ref
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Crude (unadjusted) odds ratio;

^b^Confidence interval;

^c^Adjusted odds ratio;

^d^World Health Organization;

^e^Tuberculosis

\*P-value\<0.05

With regards to marital status, being a widow was significantly associated with undernutrition in that undernutrition was about two times more likely among widowed patients than married patients (AOR = 1.7, 95% CI, 1.03--2.79).

The odds of undernutrition was more likely among patients who didn't access to water supply compared to those patients that did access to water supply (AOR = 1.69, 95% CI, 1.16--2.47).

Undernutrition was about two times and three times more likely among patients in the WHO clinical stage of three (AOR = 1.99, 95% CI, 1.33--2.97) and four (AOR = 2.97, 95% CI, 1.74--5.07) compared to patients in the WHO clinical stage of one, respectively.

HIV/AIDS patients with CD4 cell count \<200 cells/mm^3^ were two times more likely under nourished than patients with CD4 cell count ≥200 cells/mm^3^ (AOR = 1.85, 95% CI, 1.38--2.47).

Moreover, the odds of undernutrition was more likely among patients with ambulatory (AOR = 2.41, 95% CI, 1.66--3.51) and bedridden (AOR = 3.59, 95% CI, 1.55--8.35) functional status than those patients with working functional status, respectively.

In the bivariate logistic regression analysis, employment status, HIV disclosure status, being diagnosed for active TB and attending HIV related health education sessions were significantly associated with undernutrition. However, the associations of these variables were not maintained after adjusting for all independent variables.

Discussion {#sec016}
==========

This study was primarily intended to estimate the prevalence of undernutrition and identify the potential predictors of undernutrition among adult HIV/AIDS patients who were enrolled on care or who were on ART treatments. It was also aimed to estimate the prevalence of overweight or obesity among adult HIV/AIDS patients.

The study have indicated that the overall prevalence of undernutrition and overweight or obesity were 34% and 9%, respectively. Out of undernutrition, severe malnutrition (BMI\<16 kg/m^2^) accounted of 9%. We found that patients marital status, access to water supply, WHO clinical staging, CD4 cell count and functional status were significantly associated with undernutrition.

The prevalence of undernutrition was higher compared to studies conducted in different parts of Ethiopia; 12.3% in Dilla university hospital \[[@pone.0229883.ref011]\], 25.2% in Butajira hospital \[[@pone.0229883.ref010]\], 18.2% in Arba Minch area public health facilities \[[@pone.0229883.ref020]\], 30% in East Hararghe zone hospitals \[[@pone.0229883.ref021]\] and 27% in Nekemte referral hospital \[[@pone.0229883.ref022]\]. Similarly, the prevalence is also much higher compared to studies done in different parts of the world; 19.5% in Tanzania \[[@pone.0229883.ref006]\], 10% in Zimbabwe \[[@pone.0229883.ref007]\] and 19.2% in Senegal \[[@pone.0229883.ref009]\]. The difference in prevalence of malnutrition might be due to difference in socio-economic and other factors that may predispose the community to problem, such as food habit and culture. However, the prevalence of severe malnutrition (BMI\<16kg/m^2^) was comparable to studies done at Tanzania (9%) \[[@pone.0229883.ref006]\] and Butajira hospital(9%) \[[@pone.0229883.ref010]\].

In our study undernutrition was higher among female patients than male. This is comparable to other studies done in different parts of Ethiopia; Southern \[[@pone.0229883.ref011]\] and Eastern Ethiopia \[[@pone.0229883.ref021]\]. Yet different from studies done in SSA countries \[[@pone.0229883.ref006],[@pone.0229883.ref007]\] and slightly higher among male patients in study done in Butajira hospital, Southern Ethiopia \[[@pone.0229883.ref010]\]. This implies that undernutrition is more common among females and this might be related to the socio-economic status of women, access to information and other predisposing factors that may affect food intake of women in the community \[[@pone.0229883.ref023]\]. In Ethiopia, most women were already undernourished than men in the general population. For instance, 24% of women aged 15--49 years were anemic and 22% were thin (BMI\<18.5 kg/m^2^) \[[@pone.0229883.ref018]\]. Further, lower proportion of female were attended school compared to male and the employment status was much higher among men than women. Similarly, most women were not accessed to mass media and internet compared to men \[[@pone.0229883.ref018]\].

Our study also revealed that, undernutrition was higher in younger, married, primary education level and unemployed patients compared to their counter parts. As the age of patient's increased, the prevalence of undernutrition was decreased in the study area. This is comparable with studies done in different parts of the world \[[@pone.0229883.ref006],[@pone.0229883.ref007]\] and Ethiopia \[[@pone.0229883.ref010],[@pone.0229883.ref021]\], where undernutrition is more prevalent among the younger adults and overweight is more prevalent among older patients. Additionally, studies also supports the higher proportion of undernutrition among unemployed patients and patients in the lower educational status \[[@pone.0229883.ref011],[@pone.0229883.ref024],[@pone.0229883.ref025]\]. While studies done in Northern and Southern Ethiopia indicated contradicting finding in which undernutrition was higher in older age \[[@pone.0229883.ref011],[@pone.0229883.ref026]\]. Undernutrition was also much higher in patients in WHO clinical stage three and four, CD4 cell count less than 200 cells/mm^3^ and in patients with a past opportunistic infections. This indicates interlink between HIV infection and poor nutritional status. HIV compromises the nutritional status and poor nutrition further weakens the immune system of individuals, increasing susceptibility to opportunistic infections \[[@pone.0229883.ref002],[@pone.0229883.ref023],[@pone.0229883.ref027],[@pone.0229883.ref028]\].

In the multivariate logistic regression, patient marital status, access to water supply, WHO clinical staging, CD4 cell count and functional status were statistically associated with undernutrition in the study area. In the binary logistic regression variables such as employment status, being diagnosed for active TB, attending HIV related health education sessions and HIV disclosure status of patients were significantly associated with undernutrition. Though, these variables didn't show a statistical significant associations while adjusted for other variables.

Our study revealed that, being a widow and poor access to water supply were significantly associated with undernutrition among HIV/AIDS patients. The association between marital status and undernutrition could might be due to the relationship of marital status and household headship and other social and economic status of individuals \[[@pone.0229883.ref023],[@pone.0229883.ref029]\]. It might be also related to psychological conditions of individuals, where married patients better follow HIV treatments as they get required supports from their partners. On the other hand, the association of undernutrition and access to water supply is due to the fact that poor sanitation was related to diseases in patients and disease in itself leads to poor nutritional status of individuals \[[@pone.0229883.ref030],[@pone.0229883.ref031]\].

HIV/AIDS patients who were in the WHO clinical stage of three and four were two times and three times more likely undernourished compared to those in the WHO clinical stage of one, respectively. Additionally, the odds of undernutrition was more likely among patients with CD4 cell count of \<200 cells/mm^3^ and patients with functional status of bedridden and ambulatory. Undernutrition was nearly four times and two times more likely among bedridden and ambulatory patients compared to patients who have a working functional status, respectively. Our findings were supported by other studies done in other settings else \[[@pone.0229883.ref006],[@pone.0229883.ref007],[@pone.0229883.ref010],[@pone.0229883.ref011],[@pone.0229883.ref013],[@pone.0229883.ref020],[@pone.0229883.ref021],[@pone.0229883.ref024]--[@pone.0229883.ref026]\].

Undernutrition was the major factor in ensuring treatment effectiveness and thus, nutritional assessments, care and support for HIV/AIDS patients should be strengthened. Poor adherence to HIV treatments or drug is caused by lack of access to food or food insecurity. On the other hand, poor treatment adherence leads to infections and suppressed immunity of patients \[[@pone.0229883.ref009]\]. Mortality is more likely among immune compromised HIV/AIDS patients and supplementation of therapeutic food can improve the nutritional status of patients \[[@pone.0229883.ref032]\].

Our study have assessed the prevalence of malnutrition (undernutrition and overweight or obesity) among patients who were enrolled in care in the period between 2010 and 2016. Sufficient sample size was used to estimate the prevalence of both undernutrition and overweight or obesity. Yet, our study has the following limitations. The study was based on secondary data (chart review) and thus, may not address all of the variables that may affect undernutrition and may be subject to incomplete data bias.

Conclusion {#sec017}
==========

This study showed that the prevalence of malnutrition (both undernutrition and overweight) was high compared to other settings in Ethiopia. It was also revealed that WHO clinical AIDS staging three and four, CD4 cell count \<200 cells/mm^3^, functional status, patient marital status and access to water supply were significantly associated with undernutrition among adult HIV/AIDS patients. This calls the government to give due attention to strengthening the HIV/AIDS treatment, care and support services at hospitals. HIV/AIDS treatment services should be supported with nutritional assessment, supplementation, counseling, care and support to patients. A comprehensive nutritional assessment and support should be provided for all patients who are on a follow-up care. Moreover, community support to patients should be strengthened, as social determinants of health may also interact with the effectiveness HIV/AIDS treatments.
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======================
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We appreciate the comments provided by the editor and reviewers on the original research article submitted to PLOS ONE. In this letter we would like to provide our responses both for the comments provided by the editor and the reviewers separately.

Response to the Editor:

A per the comments provided by the Editor, we have modified the formats of the manuscript (the Title page and tables/figures) to be compatible with the PLOS ONE guidelines.

Regarding to the ethics statement, all patient's data were initially anonymized in that we have accessed all patient records with only their unique ART number. Though, as this unique ART number might let identification of patients; patient data were collected by using unique codes for each records starting from 1001. As data were collected from secondary sources (patient records), we were unable to take informed consent from each patients. Instead, we have obtained a permission from authorities of the Medical Center based on the approval letter received from the Ethical Review Committee. The requirements of informed consent was waived by the IRB or ethics committee.

With regards to data sharing, we have included the de-identified or anonymized patient data into the supplementary information's. The format of data included in the supplementary information's was excel or spreadsheets.

Finally, the corresponding author have created ORCID iD and it was validated by Editorial manager.

Response to the reviewers:

Response to reviewer 1:

The main aim of this article was to estimate the prevalence of undernutrition and identify the predictors of undernutrition in adult HIV/AIDS patients on follow-up care. We have also estimated the prevalence of overweight or obesity among HIV/AIDS patients. This is the reason why we have defined the title as the prevalence of malnutrition instead of undernutrition and we repeatedly utilized the term malnutrition in the manuscript.

We have addressed the detail description of the study methods (study design, study population and participant's selection processes) in the methods and materials section of the current or revised manuscript. In addition we have also clearly presented the study participation in the results section of the manuscript with support of the study flow diagram (Fig 1). Out of the total study participants (n=1062), normal nutrition, under nutrition and overweight or obesity accounted of 614, 357 and 91; respectively. The missing data (9%) in the previous version of the manuscript was observed as we didn't clearly indicate the denominator in estimating overweight or obesity (lack of clarity in data presentation). Overall, in this version of the manuscript; we tried to adequately address the comments provided in the methods and results section by the reviewer.

As we have used secondary data for this specific article and only limited variables were included, we didn't assess the food insecurity and wealth index of patients. Hence, the variables addressed were limited to the one presented in this article/manuscript.

We have addressed the comments provided in the results section. We have merged table 1, 2 and 3. Hence, the total number of tables in the manuscript was reduced to 3. We have also incorporated the comments provided in the 'Prevalence of malnutrition' sub-heading of the Results section of the manuscript. Additionally, we have also addressed the minor comments provided by the reviewer.

Response to reviewer 2:

Most of the comments provided by the reviewer are related to the clarity of the method section and language. In the revised version of the manuscript, we have clearly presented the study methods (including the study design, study population, sampling, inclusion/exclusion criteria and analysis). We have also revised the language.

Kindly regards,
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